Back to Authors

Slocumb, Nancy L.

A5012662745 | I1330342723

Mayo Clinic

Mayo Clinic

Citations 4

Treatment Outcomes in REM Sleep Behavior Disorder (P05.022)

Neurology | December 7, 2023 | Volume: 80 | Issue: 7_supplement | Pages: No page available

10.1212/wnl.80.7_supplement.p05.022

Characterizing the Emotions That Trigger Cataplexy

The Journal of Neuropsychiatry and Clinical Neurosciences | December 17, 2014 | Volume: 17 | Issue: 1 | Pages: 45-50

10.1176/jnp.17.1.45 | PMID 15746482

Restless legs syndrome and daytime sleepiness are prominent in myotonic dystrophy type 2

Neurology | June 8, 2013 | Volume: 81 | Issue: 2 | Pages: 157-164

10.1212/wnl.0b013e31829a340f | PMID 23749798

Maxillomandibular Advancement in the Management of Obstructive Sleep Apnea

International Journal of Otolaryngology | January 29, 2012 | Volume: 2012 | Issue: No issue available | Pages: 1-8

10.1155/2012/373025 | PMID 22518154

Maxillomandibular advancement (MMA) is a surgical option for obstructive sleep apnea (OSA). MMA involves forward-fixing the maxilla and mandible approximately 10 mm via Le Fort I maxillary and sagittal split mandibular osteotomies. We retrospectively reviewed outcomes from 24 consecutive OSA patients who underwent MMA at our institution. MMA resulted in an 83% reduction in the group mean apnea-hypopnea index (AHI) per polysomnography an average of 6.7 months after surgery. Forty-two percent of patients achieved a post-MMA AHI of less than 5 events/hour sleep and 71% achieved an AHI less than or equal to 10 events/hour sleep. The Epworth Sleepiness Scale score decreased by an average of 5 post-surgery. No parameters predictive of cure for OSA by MMA were identified.